Society for Endocrinology - a world-leading authority on hormones

Clinical practice

Future of Endocrinology working group

COVID-19 marks a watershed moment in history as we have all had to change our way of working, beyond going digital. Our current clinical service models need radical change, with better use of digital services, new service models, streamlined referral and better integration with primary care.

We now have a once in a lifetime opportunity to innovate and to create endocrinology services fit for the 21st century and beyond. The Society for Endocrinology is going to be at the front of this transformation and has set up a working group to define how endocrinology services should be delivered in the UK. The group will report into the Society’s Clinical Committee and will consult externally as required.

Working group members

  • Kristien Boelaert, Birmingham (co-Chair)
  • John Newell-Price, Sheffield (co-Chair)
  • Afroze Abbas, Leeds
  • Antonia Brooke, Exeter
  • Ashwin Joshi, Sunderland
  • Christine May, Oxford
  • Douglas Robertson, Mid Cheshire
  • Helen Simpson, London (UCLH)
  • Helena Gleeson, Birmingham (Queen Elizabeth)
  • Kate Laycock, London (Homerton University Hospital, Hackney)
  • Maralyn Druce, London (St Barts Hospital, Barts Trust)
  • Shazia Hussain, London (Royal London Hospital, Barts Trust)
  • Sherwin Criseno, Birmingham (Queen Elizabeth)
  • Helen Parretti, University of East Anglia 
  • Clare Hambling, NHS Norfolk
  • Philip Newland-Jones, University Hospitals Southampton

Three initial work packages have been identified to cover the remit of the working group:

  1. Planning for COVID-19 second wave
  2. Sharing best practice: resources and tools
  3. Pathways and networks

All members will have the opportunity to contribute and final recommendations will be put forward to all relevant organisations in the coming months.